SYNVANTAGE Trademark

Trademark Overview


On Friday, August 7, 2020, a trademark application was filed for SYNVANTAGE with the United States Patent and Trademark Office. The USPTO has given the SYNVANTAGE trademark a serial number of 90100048. The federal status of this trademark filing is REGISTERED as of Tuesday, July 23, 2024. This trademark is owned by Syngene International Limited. The SYNVANTAGE trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Autonomic drugs for medical purposes for treatment of diseases and conditions in the fields of oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Diagnostic preparations for medical or veterinary purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for treating diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dent...

Chemicals for use in biotechnological manufacturing processes and product development; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Chemicals for use in industry and science; Biological preparations for use in industry and science; Enzymes derived from biotechnological processes for use in industry; enzyme substrates; enzyme stabilizers; Enzymes for scientific and research purposes; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory, research, clinical or medical laboratory use; chitosans for industrial purposes; aldehydes; chromatography chemicals; Stem cells for research purposes; cells for scientific, laboratory or medical researc...

Drug, alcohol and DNA screening for medical purposes; medical services; medical and pharmaceutical consultation; Medical diagnostic testing, monitoring and reporting services; pathology services for medical and diagnostic purposes

Development of pharmaceutical preparations and medicines; Drug discovery services; Pharmaceutical drug development services; Scientific study and research in the fields of medicine, the prevention, treatment and management of illness, health care delivery; medical research services; pharmaceutical research services; laboratory research services relating to pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Conducting clinical trials for others; biological and chemical research; bacteriological research; Biological research and analysis; custom design and development of chemical reagents and biochemical assays; laboratory testing services for research and development purposes; testing of pharmaceuticals; chemical engineering; scientific study and research in the field of reproduction, husbandry, and general health of animal; biotechnology research for determining the neurona...
synvantage

General Information


Serial Number90100048
Word MarkSYNVANTAGE
Filing DateFriday, August 7, 2020
Status700 - REGISTERED
Status DateTuesday, July 23, 2024
Registration Number7452470
Registration DateTuesday, July 23, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2024

Trademark Statements


Goods and ServicesAutonomic drugs for medical purposes for treatment of diseases and conditions in the fields of oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Diagnostic preparations for medical or veterinary purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for treating diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Dietary supplements for humans and animals; Biological tissue cultures for medical purposes; Biological preparations for the treatment of diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Pharmaceutical preparations for the treatment of infectious diseases; Bio-logical and biotechnological products pertaining to pharmaceutical and medical industries and formulations thereof for pharmaceutical and medical use, namely, pharmaceutical preparations for the treatment of diseases and conditions in the fields of oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; synthetic peptides for pharmaceutical purposes and for the treatment of diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; imaging agents for magnetic resonance imaging (MRI); nucleic acid sequences and chemical reagents for medical and veterinary purposes; pharmaceutical preparations and substances for the treatment of diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; biological tissue grafts; vascular grafts comprised of living tissue; biopharmaceuticals for the treatment of cancer; yeast and yeast extracts for medical, veterinary or pharmaceutical purposes; Protein arrays for medical diagnosis purposes; medicines for veterinary purposes for the treatment of skin allergies, ehrlichiosis, ear infection, diabetes, kennel cough, upper respiratory tract infection, coccidiosis, babesiosis, ectoparasites, endoparasites; isotopes for medical purposes; chemical preparations for medical purposes for use in DNA analysis; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Contrast media for in vivo imaging; Contrast agents for use in molecular imaging
Goods and ServicesChemicals for use in biotechnological manufacturing processes and product development; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Chemicals for use in industry and science; Biological preparations for use in industry and science; Enzymes derived from biotechnological processes for use in industry; enzyme substrates; enzyme stabilizers; Enzymes for scientific and research purposes; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory, research, clinical or medical laboratory use; chitosans for industrial purposes; aldehydes; chromatography chemicals; Stem cells for research purposes; cells for scientific, laboratory or medical research; Reagents for scientific and research use; nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; nucleotides for scientific and research use; Protein for industrial use; Proteins for use in manufacture; specialty chemicals, namely, chemical additives for general industrial use in the manufacture of a wide variety of goods; chemical reference standards for use in science and industry; isotopes for industrial purposes; biochemicals for in vitro and in vivo scientific use; Nucleic acid sequences, other than for medical or veterinary purposes; Reagents for scientific purposes for use in nucleic acid isolation and purification; gels, reagents, chemical standards, dyes and trace dyes for electrophoresis, other than for medical or veterinary purposes; preparative electrophoresis reagents, other than for medical or veterinary purposes
Goods and ServicesDrug, alcohol and DNA screening for medical purposes; medical services; medical and pharmaceutical consultation; Medical diagnostic testing, monitoring and reporting services; pathology services for medical and diagnostic purposes
Goods and ServicesDevelopment of pharmaceutical preparations and medicines; Drug discovery services; Pharmaceutical drug development services; Scientific study and research in the fields of medicine, the prevention, treatment and management of illness, health care delivery; medical research services; pharmaceutical research services; laboratory research services relating to pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Conducting clinical trials for others; biological and chemical research; bacteriological research; Biological research and analysis; custom design and development of chemical reagents and biochemical assays; laboratory testing services for research and development purposes; testing of pharmaceuticals; chemical engineering; scientific study and research in the field of reproduction, husbandry, and general health of animal; biotechnology research for determining the neuronal survival of molecules in animal models; research and development services in the field of antibodies, antibody technology, immunopharmaceuticals and vaccines; design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; toxicology services; toxicity testing for research purposes; conducting clinical trials for others in the field of pharmaceutical products; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; DNA analysis services for scientific research purposes; laboratory research in the field of gene expression; blood analysis services for scientific research purposes; analysis of human tissues for medical research; scientific services relating to the isolation and cultivation of human tissues and cells for research purposes; preparation of reports relating to scientific and technical research; analysis in the field of molecular biology; contract scientific research services relating to molecular sciences; biological cloning services; structural and functional analysis of genomes; scientific and medical laboratory services; services of a chemical and biological laboratory for research purposes; research and development and consultation related thereto in the field of antibodies, antibody technology, chemistry, agrochemical pharmaceuticals, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell lines, chemoinformatic, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymers, peptide synthesis, protein, and solid state characterization; scientific and technological services, namely, scientific research, development, analysis, testing, and technological services, namely, scientific research, development, analysis, testing, engineering, extraction, synthesis, purification and production in the field of antibodies, active pharmaceutical ingredients (API), biomolecules, cell bank characterization, chirality, chromosome aberration, clinical chemistry, cloning vector, cyclotides, DNA, flow cytometry, gas chromatography mass spectrometry, gene, immuno-pharmaceuticals, in vitro irritation, large molecule, liquid chromatography mass spectrometry, microbials, monomers, nanoparticles, natural products, peptides, proteins, RNA, supercritical fluid chromatography, small molecules and vaccines; Laboratory services, namely, imaging core lab services

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, September 9, 2020
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 9, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 9, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 9, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSyngene International Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressKarnataka Bangalore
IN

Party NameSyngene International Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressKarnataka Bangalore
IN

Party NameSyngene International Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressKarnataka Bangalore
IN

Trademark Events


Event DateEvent Description
Tuesday, August 11, 2020NEW APPLICATION ENTERED
Wednesday, September 9, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 4, 2020ASSIGNED TO EXAMINER
Tuesday, November 10, 2020NON-FINAL ACTION WRITTEN
Tuesday, November 10, 2020NON-FINAL ACTION E-MAILED
Tuesday, November 10, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 4, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, March 4, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, March 4, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 4, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, March 4, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 6, 2021PUBLISHED FOR OPPOSITION
Tuesday, April 6, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 1, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 30, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, November 30, 2021SOU EXTENSION 1 FILED
Tuesday, November 30, 2021SOU EXTENSION 1 GRANTED
Thursday, December 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 31, 202244(e) PETITION - RECEIVED
Tuesday, May 31, 2022TEAS PETITION TO AMEND BASIS RECEIVED
Wednesday, June 1, 2022SOU EXTENSION 2 FILED
Wednesday, June 22, 2022ASSIGNED TO PETITION STAFF
Monday, July 4, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 5, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, July 6, 2022SOU EXTENSION RECEIVED WITH TEAS PETITION
Friday, July 8, 2022PETITION GRANTED - EXTENSION REQUEST FILED
Friday, July 8, 2022SOU EXTENSION 2 GRANTED
Friday, July 8, 2022ASSIGNED TO PETITION STAFF
Friday, July 8, 2022PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Friday, July 8, 2022ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Friday, July 8, 2022NOTICE OF REVIVAL - E-MAILED
Saturday, July 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 20, 2022ASSIGNED TO EXAMINER
Friday, July 29, 2022ATTORNEY REVIEW COMPLETED
Friday, September 30, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Friday, September 30, 202244(e) PETITION - RECEIVED
Thursday, October 20, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 20, 2022REVIEW OF CORRESPONDENCE COMPLETE
Wednesday, November 30, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 30, 2022SOU EXTENSION 3 FILED
Wednesday, November 30, 2022SOU EXTENSION 3 GRANTED
Friday, December 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 1, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 1, 2023SOU EXTENSION 4 FILED
Thursday, June 1, 2023SOU EXTENSION 4 GRANTED
Saturday, June 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 1, 2023SOU TEAS EXTENSION RECEIVED
Friday, December 1, 2023SOU EXTENSION 5 FILED
Monday, December 4, 2023SOU EXTENSION 5 GRANTED
Tuesday, December 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 1, 2024PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Tuesday, March 5, 2024ASSIGNED TO PETITION STAFF
Wednesday, March 6, 2024PETITION INQUIRY LETTER ISSUED
Wednesday, March 27, 2024TEAS RESPONSE TO PETITION INQUIRY LETTER
Monday, April 1, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, April 3, 2024NOTICE OF ALLOWANCE CANCELLED
Wednesday, April 3, 2024CASE RETURNED TO EXAMINATION
Wednesday, April 3, 2024ATTORNEY REVIEW COMPLETED
Wednesday, April 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 7, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 7, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 23, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED